Antivax Chronicles: Covid Vaccine Supply Will Soon Outpace Demand in the U.S.

Antivax Chronicles: Covid Vaccine Supply Will Soon Outpace Demand in the U.S.
The rollout of the Covid-19 vaccine in America under the Joe Biden administration has been a historic success. As of this week, more than 200 million shots have been administered — doubling the president’s original 100 day goal. Among vulnerable seniors, 81 percent have gotten at least one shot, as have more than 40 percent of working adults. And this week, the last eligibility constraints were lifted: Americans over 16 years old are now eligible to receive a vaccine.

This is unalloyed good news. But the wide availability of vaccines is pushing America toward an odd tipping point.
See full article at Rolling Stone »

Similar News


Recently Viewed